BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15555143)

  • 1. Schizophrenia.
    Nadeem Z; McIntosh A; Lawrie S
    Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia.
    McIntosh A; Lawrie S
    Clin Evid; 2004 Dec; (12):1502-33. PubMed ID: 15865730
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenia.
    Lawrie S; McIntosh A; Nadeem Z
    Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Atypical antipsychotics].
    Naber D
    Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Zotepin--its value and potentials for further development].
    Nervenarzt; 1994 Jul; 65(7 Suppl):1-8. PubMed ID: 9218060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Late schizophrenia].
    Morishita S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):80-3. PubMed ID: 12876935
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute respiratory distress due to antipsychotic drugs.
    Yagmur F; Ulusoy HB; Buyukoglan H; Kaya MG
    Pharmacopsychiatry; 2010 May; 43(3):118-9. PubMed ID: 20446229
    [No Abstract]   [Full Text] [Related]  

  • 12. Amisulpride augmentation of clozapine in refractory schizophrenia.
    Chiu HW; Ku YC; Li TC; Huang HT
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
    [No Abstract]   [Full Text] [Related]  

  • 13. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
    Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
    Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dystonia induced by switch of atypical antipsychotics.
    Chen CC; Chen YY; Hung GC
    Pharmacopsychiatry; 2010 Jul; 43(5):200-1. PubMed ID: 20486043
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting cognition in schizophrenia research: from etiology to treatment.
    Goldberg TE; Gomar JJ
    Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
    Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
    Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to amisulpride due to hepatic complications.
    Yagdiran O; Haasen C; Nika E; Krausz M; Naber D
    Eur Psychiatry; 2002 May; 17(3):170-1. PubMed ID: 12052579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.